» Articles » PMID: 38786163

Carbapenem-Resistant NDM and OXA-48- Producing : From Menacing Superbug to a Mundane Bacteria; A Retrospective Study in a Romanian Tertiary Hospital

Overview
Specialty Pharmacology
Date 2024 May 24
PMID 38786163
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Carbapenem-resistant (Cr-Kpn) is becoming a growing public health problem through the failure of adequate treatment. This study's objectives are to describe the sources of Cr-Kpn in our hospital over 22 months, associating factors with the outcome of Cr-Kpn-positive patients, especially those with NDM+OXA-48- (New Delhi Metallo-β-Lactamase and oxacillinase-48) and the effectiveness of the treatments used.

Methods: A retrospective observational cohort study including all hospitalized patients with Cr-Kpn isolates. We reported data as percentages and identified independent predictors for mortality over hospital time through multivariate analysis.

Results: The main type of carbapenemases identified were NDM+OXA-48- (49.4%). The statistical analysis identified that diabetes and co-infections with the Gram-negative, non-urinary sites of infection were factors of unfavorable evolution. The Cox regression model identified factors associated with a poor outcome: ICU admission (HR of 2.38), previous medical wards transition (HR of 4.69), and carbapenemase type NDM (HR of 5.98). We did not find the superiority of an antibiotic regimen, especially in the case of NDM+OXA-48-.

Conclusions: The increase in the incidence of Cr-Kpn infections, especially with NDM+OXA-48- pathogens, requires a paradigm shift in both the treatment of infected patients and the control of the spread of these pathogens, which calls for a change in public health policy regarding the use of antibiotics and the pursuit of a One Health approach.

Citing Articles

Rapid Simultaneous Detection of the Clinically Relevant Carbapenemase Resistance Genes KPC, OXA48, VIM and NDM with the Newly Developed Ready-to-Use qPCR CarbaScan LyoBead.

Reinicke M, Diezel C, Teimoori S, Haase B, Monecke S, Ehricht R Int J Mol Sci. 2025; 26(3).

PMID: 39940986 PMC: 11818240. DOI: 10.3390/ijms26031218.


Bacterial Infections, Trends, and Resistance Patterns in the Time of the COVID-19 Pandemic in Romania-A Systematic Review.

Vulcanescu D, Bagiu I, Avram C, Oprisoni L, Tanasescu S, Sorescu T Antibiotics (Basel). 2025; 13(12.

PMID: 39766609 PMC: 11726834. DOI: 10.3390/antibiotics13121219.


Comparison of Carbapenemases and Extended-Spectrum β-Lactamases and Resistance Phenotypes in Hospital- and Community-Acquired Isolates of from Croatia.

Car H, Dobric M, Pospisil M, Nad M, Luxner J, Zarfel G Microorganisms. 2024; 12(11).

PMID: 39597613 PMC: 11596078. DOI: 10.3390/microorganisms12112224.

References
1.
Pitout J, Nordmann P, Poirel L . Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance. Antimicrob Agents Chemother. 2015; 59(10):5873-84. PMC: 4576115. DOI: 10.1128/AAC.01019-15. View

2.
Nordmann P, Naas T, Poirel L . Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011; 17(10):1791-8. PMC: 3310682. DOI: 10.3201/eid1710.110655. View

3.
Abderrahim A, Djahmi N, Loucif L, Nedjai S, Chelaghma W, Gameci-Kirane D . Dissemination of OXA-48- and NDM-1-Producing Enterobacterales Isolates in an Algerian Hospital. Antibiotics (Basel). 2022; 11(6). PMC: 9220339. DOI: 10.3390/antibiotics11060750. View

4.
Obeng-Nkrumah N, Labi A, Blankson H, Awuah-Mensah G, Oduro-Mensah D, Anum J . Household cockroaches carry CTX-M-15-, OXA-48- and NDM-1-producing enterobacteria, and share beta-lactam resistance determinants with humans. BMC Microbiol. 2019; 19(1):272. PMC: 6894353. DOI: 10.1186/s12866-019-1629-x. View

5.
Virolle C, Goldlust K, Djermoun S, Bigot S, Lesterlin C . Plasmid Transfer by Conjugation in Gram-Negative Bacteria: From the Cellular to the Community Level. Genes (Basel). 2020; 11(11). PMC: 7690428. DOI: 10.3390/genes11111239. View